Chef Israel Aharoni Reveals Prostate Cancer Diagnosis, Highlights Early Detection Importance

Chef Israel Aharoni recently disclosed his diagnosis with prostate cancer, bringing renewed attention to the most common cancer among men in Israel and the Western world. According to the Israeli Ministry of Health and the Israel Cancer Association, prostate cancer risk increases with age, yet many men remain unaware that the disease often develops without symptoms. Professor David Margel, head of innovation, research, and risk management at Assuta Ramat Hahayal, emphasized that prostate cancer usually progresses silently, making regular screening crucial even for men who feel healthy.

Professor Margel recommends that most men discuss prostate cancer screening with their doctors around age 50, while those with a family history or genetic mutations such as BRCA should consider earlier monitoring. Symptoms like frequent nighttime urination, weak urine flow, urgency, or difficulty emptying the bladder may indicate prostate issues but are not definitive for cancer, as benign prostate enlargement is common in older men. Nonetheless, any significant urinary changes warrant medical evaluation.

Diagnostic methods have evolved significantly. The PSA blood test remains a key early detection tool but is insufficient alone due to false positives from non-cancerous conditions. Currently, an MRI of the prostate is typically performed before deciding on a biopsy, improving accuracy and reducing unnecessary procedures. Biopsy techniques have also advanced, with a shift from transrectal to safer transperineal approaches that lower infection risks. Robotic systems like Biobot Mona Lisa combine MRI and real-time ultrasound to precisely target suspicious areas, minimizing needle passes.

Early diagnosis enables personalized treatment plans, ranging from active surveillance to surgery, radiation, or advanced drug therapies. Professor Margel stressed, "The most important message is not to wait for pain." Thanks to improved imaging and biopsy technologies, prostate cancer can now be detected earlier, allowing tailored treatments that often preserve patients' quality of life.